Europe Pharmaceuticals & Healthcare Products (44)
-
Belarus Pharmaceuticals & Healthcare Report
Pub date: 16 Jan 2012 Europe / Belarus Pharmaceuticals & Healthcare Industry Report
BMI View: The Belarusian pharmaceutical market has strong long-term potential given its position bordering the EU and Russia, its demographic profile and still low per capita spending on pharmaceuti... Read MoreWeb Price: $995 -
Belgium Pharmaceuticals & Healthcare Report
Pub date: 09 Dec 2011 Europe / Belgium Pharmaceuticals & Healthcare Industry Report
BMI View: The expected growth of Belgium’s ageing population will have an unprecedented effect on the provision of healthcare. The elderly require more medical check-ups and care than young people du... Read MoreWeb Price: $995 -
Bulgaria Pharmaceuticals & Healthcare Report
Pub date: 15 Dec 2011 Europe / Bulgaria Pharmaceuticals & Healthcare Industry Report
BMI View: Out-of-pocket spending will continue to be the main driver behind the growth of Bulgaria’s pharmaceutical market, though this feature also makes the market highly vulnerable to the wider e... Read MoreWeb Price: $995 -
Croatia Pharmaceuticals & Healthcare Report
Pub date: 10 Nov 2011 Europe / Croatia Pharmaceuticals & Healthcare Industry Report
BMI View: At best, Croatia’s pharmaceutical market will continue to represent a very modest prospect for foreign companies. A subdued demographic outlook and economic difficulties, which are also we... Read MoreWeb Price: $995 -
Czech Republic Pharmaceuticals & Healthcare Report
Pub date: 18 Jan 2012 Europe / Czech Republic Pharmaceuticals & Healthcare Industry Report
BMI View: It is now clear that the Czech Republic pharmaceutical and healthcare market will be under intense pressures in 2012, with the combination of drug policy reforms and a worsening economic o... Read MoreWeb Price: $995 -
Estonia Pharmaceuticals & Healthcare Report
Pub date: 10 Nov 2011 Europe / Estonia Pharmaceuticals & Healthcare Industry Report
BMI View: Estonia’s pharmaceutical market will remain of marginal interest to multinationals, given its small population size and a modest growth outlook. We expect the market to post a five-year com... Read MoreWeb Price: $995 -
France Pharmaceuticals & Healthcare Report
Pub date: 21 Dec 2011 Europe / France Pharmaceuticals & Healthcare Industry Report
BMI View: Despite the government’s focus on fiscal consolidation – which includes various costcontainment measures impacting the country’s healthcare and pharmaceutical spending – France will remain... Read MoreWeb Price: $995 -
Germany Pharmaceuticals & Healthcare Report
Pub date: 16 Dec 2011 Europe / Germany Pharmaceuticals & Healthcare Industry Report
BMI View: We view Germany as the fifth most attractive pharmaceutical market globally. A large population and the government’s contribution to healthcare funding will continue to support absolute ph... Read MoreWeb Price: $995 -
Greece Pharmaceuticals & Healthcare Report
Pub date: 10 Jan 2012 Europe / Greece Pharmaceuticals & Healthcare Industry Report
BMI View: It is beyond doubt that drugmakers in Greece – particularly domestic producers primarily exposed to their home market – are faced with the most challenging operating environment in Europe. ... Read MoreWeb Price: $995 -
Hungary Pharmaceuticals & Healthcare Report
Pub date: 18 Nov 2011 Europe / Hungary Pharmaceuticals & Healthcare Industry Report
BMI View: While we lowered our projections for Hungary's pharmaceutical market in response to the government's structural reform programme at the start of 2011, we continue to believe the reported m... Read MoreWeb Price: $995 -
Italy Pharmaceuticals & Healthcare Report
Pub date: 09 Dec 2011 Europe / Italy Pharmaceuticals & Healthcare Industry Report
BMI View: Under pressure from jittery financial markets, a new Italian government led by Prime Minister Mario Monti was sworn in on November 16 2011, just four days after the resignation of Silvio B... Read MoreWeb Price: $995 -
Kazakhstan Pharmaceuticals & Healthcare Report
Pub date: 09 Dec 2011 Europe / Kazakhstan Pharmaceuticals & Healthcare Industry Report
BMI View: We remain convinced that Kazakhstan is the most accessible pharmaceutical market in Central Asia. The government has committed to investing in healthcare and expanding medicines provision ... Read MoreWeb Price: $995 -
Latvia Pharmaceuticals & Healthcare Report
Pub date: 18 Nov 2011 Europe / Latvia Pharmaceuticals & Healthcare Industry Report
BMI View: Latvia’s attractiveness to multinationals will continue to be negatively impacted by the government’s cost-containment measures and the wider macroeconomic performance, especially as much ... Read MoreWeb Price: $995 -
Lithuania Pharmaceuticals & Healthcare Report
Pub date: 16 Jan 2012 Europe / Lithuania Pharmaceuticals & Healthcare Industry Report
BMI View: Demographic considerations – in combination with concerted cost-containment pressures that form part of fiscal austerity measures – will continue to hamper the development of the Lithuanian... Read MoreWeb Price: $995 -
Moldova Pharmaceuticals & Healthcare Report
Pub date: 15 Dec 2011 Europe / Moldova Pharmaceuticals & Healthcare Industry Report
BMI View: Moldova’s small market size and its status as the poorest countries in Europe limit its attractiveness as a destination for investment. However, it is the most liberal country in the Commo... Read MoreWeb Price: $995 -
Netherlands Pharmaceuticals & Healthcare Report
Pub date: 10 Nov 2011 Europe / Netherlands Pharmaceuticals & Healthcare Industry Report
BMI View: The Netherlands boasts a well-developed healthcare system and also an advanced pharmaceutical industry, which has attracted significant domestic and foreign investment over the years. Demo... Read MoreWeb Price: $995 -
Poland Pharmaceuticals & Healthcare Report
Pub date: 30 Nov 2011 Europe / Poland Pharmaceuticals & Healthcare Industry Report
BMI View: While 2012 is set to be a particularly challenging year for drugmakers operating in Poland, we do not believe that the impact of the Drug Reimbursement Act of May 2011, will lead to a marke... Read MoreWeb Price: $995 -
Portugal Pharmaceuticals & Healthcare Report
Pub date: 09 Dec 2011 Europe / Portugal Pharmaceuticals & Healthcare Industry Report
BMI View: The EU/IMF economic rescue package, approved in May 2011, has widespread implications for the pharmaceutical sector, including changes to reimbursement, the obligation to prescribe by activ... Read MoreWeb Price: $995 -
Romania Pharmaceuticals & Healthcare Report
Pub date: 09 Dec 2011 Europe / Romania Pharmaceuticals & Healthcare Industry Report
BMI View: The introduction of a revised claw-back mechanism in Romania has angered drugmakers operating in the market. BMI believes the current form of the legislation is overly simplistic and punish... Read MoreWeb Price: $995 -
Russia Pharmaceuticals & Healthcare Report
Pub date: 10 Jan 2012 Europe / Russia Pharmaceuticals & Healthcare Industry Report
BMI View: Renewed liberalisation of Russia’s pharmaceutical market could follow the final approval of the country’s membership of the World Trade Organisation (WTO) at the end of 2011. Liberalisation... Read MoreWeb Price: $995 -
Serbia Pharmaceuticals & Healthcare Report
Pub date: 30 Dec 2011 Europe / Serbia Pharmaceuticals & Healthcare Industry Report
BMI View: Despite a downgrade in our economic outlook for Serbia, BMI's expenditure projections for the pharmaceutical market for 2012-2015 are up moderately due to revisions to our previous expectat... Read MoreWeb Price: $995 -
Slovakia Pharmaceuticals & Healthcare Report
Pub date: 13 Jan 2012 Europe / Slovakia Pharmaceuticals & Healthcare Industry Report
BMI View: The potential of the Slovakian pharmaceutical market in the short term has been subdued by recent legislative changes. The government's most significant and damaging measure is the introduc... Read MoreWeb Price: $995 -
Slovenia Pharmaceuticals & Healthcare Report
Pub date: 25 Nov 2011 Europe / Slovenia Pharmaceuticals & Healthcare Industry Report
BMI View: Although Slovenia is a small pharmaceutical market, the country boasts a well-developed healthcare system and solid infrastructure, propped up by high per capita spending on healthcare. Ho... Read MoreWeb Price: $995 -
Spain Pharmaceuticals & Healthcare Report
Pub date: 13 Jan 2012 Europe / Spain Pharmaceuticals & Healthcare Industry Report
BMI View: We believe the Spanish government's austerity measures are a necessary and prudent course of action. The country still has the third highest budget deficit in the eurozone and continues to ... Read MoreWeb Price: $995 -
Sweden Pharmaceuticals & Healthcare Report
Pub date: 18 Nov 2011 Europe / Sweden Pharmaceuticals & Healthcare Industry Report
BMI View: Sweden’s pharmaceutical market is expected to grow weakly over the coming years as the government’s attempts to contain health care costs focus on pharmaceutical expenditure. Having said t... Read MoreWeb Price: $995 -
Switzerland Pharmaceuticals & Healthcare Report
Pub date: 06 Feb 2012 Europe / Switzerland Pharmaceuticals & Healthcare Industry Report
BMI View: It is our view that the Swiss economy will record slower growth in 2012. This may lead to the implementation of more austerity measures which will impact the publicly funded pharmaceuticals... Read MoreWeb Price: $995 -
Turkey Pharmaceuticals & Healthcare Report
Pub date: 10 Nov 2011 Europe / Turkey Pharmaceuticals & Healthcare Industry Report
BMI View: Turkey's pharmaceutical market offers strong growth potential and will continue to be viewed as an attractive market for foreign drugmakers, particularly those who are interested in the acq... Read MoreWeb Price: $995 -
Ukraine Pharmaceuticals & Healthcare Report
Pub date: 23 Dec 2011 Europe / Ukraine Pharmaceuticals & Healthcare Industry Report
BMI View: We continue to see strong short and medium-term growth potential for the Ukrainian pharmaceutical market, with the caveat that the market faces severe and ever-present economic risks strong... Read MoreWeb Price: $995 -
United Kingdom Pharmaceuticals & Healthcare Report
Pub date: 18 Jan 2012 Europe / United Kingdom Pharmaceuticals & Healthcare Industry Report
BMI View: Highlighting the government's recognition of the importance of creating an attractive business environment for drugmakers, in early December 2011, the Prime Minister announced a series of ... Read MoreWeb Price: $995 -
Uzbekistan Pharmaceuticals & Healthcare Report
Pub date: 18 Nov 2011 Europe / Uzbekistan Pharmaceuticals & Healthcare Industry Report
BMI View: Uzbekistan is Central Asia’s largest market by population, although its pharmaceutical market lags that of neighbouring Kazakhstan in value terms, with per capita spending on pharmaceutica... Read MoreWeb Price: $995 -
Burden Of Disease Database
Pub date: 29 Sep 2008 Global / Middle East Pharmaceuticals & Healthcare Special Report
Key insights from BMI’s Burden of Disease Database, an online tool that forecasts the burden of 123 diseases in 192 countries through to 2030.... Read MoreWeb Price: $490 -
Eurozone Debt Crisis: Effects on PIIGS Pharmaceuticals Market
Pub date: 24 May 2010 Global / Middle East Pharmaceuticals & Healthcare Special Report
In this report, BMI provides an analysis of the implications of the Eurozone sovereign debt crisis on the PIIGS pharmaceutical industries, with a particular focus on the impact of the austerity measur... Read MoreWeb Price: $490 -
Global Economic Downturn: Implications For The Pharmaceutical Industry
Pub date: 16 Sep 2009 Global / North America Pharmaceuticals & Healthcare Special Report
In this special report, BMI assess the impact of the economic downturn on drug expenditure levels in markets across the globe.... Read MoreWeb Price: $490 -
Pharmaceutical Pricing: Dynamics In A Global Market
Pub date: 19 Apr 2010 Global Pharmaceuticals & Healthcare Special Report
BMI analyses pharmaceutical consumer price indices across 40 countries, identifying historic and likely future trends in pricing policies and dynamics.... Read MoreWeb Price: $490 -
US Regulatory Trends During 2010: A Rapidly Changing Environment
Pub date: 25 Jan 2011 Global / North America Pharmaceuticals & Healthcare Special Report
BMI’s analysis of regulatory approvals in 2010 says much about which drugmakers will outperform rivals throughout 2011, with biological blockbuster drugs leading the way.... Read MoreWeb Price: $490 -
Bulgaria Pharmaceuticals Competitive Intelligence Report
Pub date: 01 Nov 2010 Europe / Bulgaria Pharmaceuticals & Healthcare Competitive Intelligence Report
Ahead of EU accession, Bulgaria's pharmaceutical market experienced consolidation around a small number of large players, including Sopharma, which merged with Unipharm in 2000. Additionally, a numb... Read MoreWeb Price: $975 -
Croatia Pharmaceuticals Competitive Intelligence Report
Pub date: 01 Nov 2010 Europe / Croatia Pharmaceuticals & Healthcare Competitive Intelligence Report
Until the early 1990s, foreign companies licensed their products to be produced by domestic manufacturers. Due to increasing market opportunities and the need for product promotion, most major forei... Read MoreWeb Price: $975 -
Greece Pharmaceuticals Competitive Intelligence Report
Pub date: 02 Nov 2010 Europe / Greece Pharmaceuticals & Healthcare Competitive Intelligence Report
Greece's pharmaceutical has consolidated around stronger drugmakers in recent years, from a base of around 270 active companies in 2003. Pharmaceutical manufacturing is one of the key sub-sectors of ... Read MoreWeb Price: $975 -
Hungary Pharmaceuticals Competitive Intelligence Report
Pub date: 02 Nov 2010 Europe / Hungary Pharmaceuticals & Healthcare Competitive Intelligence Report
Pharmaceutical Industry A flurry of deal-making by both domestic companies and foreign firms and strong results (evident prior to the economic crisis) reflect dramatic improvements in the regulatory... Read MoreWeb Price: $975 -
Poland Pharmaceuticals Competitive Intelligence Report
Pub date: 01 Nov 2010 Europe / Poland Pharmaceuticals & Healthcare Competitive Intelligence Report
Pharmaceutical Industry The demand for pharmaceuticals in Poland is met through a combination of generic drugs (many of which are produced domestically) and patented products, which are mostly impor... Read MoreWeb Price: $975 -
Romania Pharmaceuticals Competitive Intelligence Report
Pub date: 02 Nov 2010 Europe / Romania Pharmaceuticals & Healthcare Competitive Intelligence Report
Romania's domestic pharmaceuticals market is fragmented, but undergoing a process of consolidation. The market is supplied by around 330 manufacturers, 30 of which are domestic. The top 10 companies ... Read MoreWeb Price: $975 -
Russia Pharmaceuticals Competitive Intelligence Report
Pub date: 01 Nov 2010 Europe / Russia Pharmaceuticals & Healthcare Competitive Intelligence Report
The Russia Pharmaceuticals Competitive Intelligence Report is an essential resource for manufacturers, investors and suppliers analysing and comparing the strategies adopted by major industry players.... Read MoreWeb Price: $975 -
Turkey Pharmaceuticals Competitive Intelligence Report
Pub date: 27 Oct 2010 Europe / Turkey Pharmaceuticals & Healthcare Competitive Intelligence Report
There are over 300 pharmaceutical companies operating in Turkey, including around 50 multinationals, which have progressively entered the country since mid-1980s. Over 23,000 people are employed in t... Read MoreWeb Price: $975 -
Multinational Pharmaceuticals Companies in Emerging Europe CD-ROM
Pub date: 01 Jan 2012 Global / Europe Pharmaceuticals & Healthcare Multinational Companies Industry Directory
Multinational Pharmaceuticals Companies in Europe CD-ROM... Read MoreWeb Price: $995